Patient-Controlled Ambient Light to Reduce Pre-Visit Anxiety in Dermatology Patients
Public ClinicalTrials.gov record NCT07896122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of a Patient-Controlled Ambient Chromotherapy Device (Serene Sphere) on Anxiety in Outpatient Dermatology
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Many patients feel anxious while waiting to see a dermatologist, especially in clinics that diagnose and treat skin cancer. The purpose of this study was to learn whether spending 10 minutes before the visit in an exam room lit by a tabletop colored-light device, which patients control themselves, lowers anxiety compared with usual room lighting. Adult patients at one Stanford dermatology clinic were assigned by clinic week: during intervention weeks the device was on and patients could choose its color and brightness with a handheld remote; during control weeks the room had standard lighting. Patients answered short questionnaires about how they felt when they arrived and again after 10 minutes in the room.
Study identification
- NCT ID
- NCT07896122
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2026 (Actual)
- Primary completion
- Aug 11, 2026 (Actual)
- Completion
- Aug 11, 2026 (Actual)
- Last update posted
- Oct 26, 2026
2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Dermatology Clinic | Redwood City | California | 94063 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07896122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07896122 live on ClinicalTrials.gov.